| Name | Title | Contact Details |
|---|
Path is a healthcare company powered by technology. We`re a teletherapy company that doesn`t compromise on quality — we measure progress and prioritize patient outcomes. Path takes a patient-first approach, where treatment is more accessible, personalized, and effective. With Path, it`s easy to find a high-quality therapist or psychiatric practitioner who meets your unique needs, accepts insurance, and is taking new patients. For providers, Path offers the flexibility of private practice, while also filling caseloads and offering the necessary behind-the-scenes support. Path handles the marketing, credentialing, billing, and admin tasks so providers can focus on what they love: providing care to those in need. With no minimum caseload required and guaranteed payments, Path is a trusted partner for more than 8,000 therapists nationwide and has hundreds of 5-star reviews. Our mission is to make mental healthcare work for everyone. Path is a 100% remote healthtech company and we`re hiring! We have teams who specialize in the areas of Clinical, Finance, Operations, Marketing, Engineering, Product, and more. We`re excited to bring people onto the team who are committed to changing how mental health is treated.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Orthopaedic Specialists of North Carolina is a medical practice that provides orthopedic care and services to patients in the Raleigh, North Carolina area. They offer a patient-friendly atmosphere and use innovative and advanced technology to provide a...
iMedicor, Inc. is a national provider of comprehensive secure communications solutions for the medical and dental communities. iMedicor offers dentists, general practitioners, specialized doctors and other healthcare professionals the use of a secure, HIPAA-compliant communications network that addresses current federal standards for security and interoperability. iMedicor also serves as one of the country's leading Meaningful Use consultants to assist doctors and dentists with conversion from paper to electronic health records (EHRs) and qualify under Medicare and Medicaid guidelines for Federal Incentive Funding.
Northwest Florida Blood Ctr is a Pensacola, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.